How to Optimise Therapy for heart failure with reduced ejection fraction
The prognosi s for patients with heart failure is poor, with high rates of hospitalisation and mortality. It is essential to optimise pharmacotherapy and device therapies that improve the prognosis for patients with heart failure with reduced ejection fraction.
Modern Medicine – Issue 2 2021
